Related Experiment Video
Updated: Jun 28, 2026
09:48
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Adipokines and insulin resistance.
Katja Rabe1, Michael Lehrke, Klaus G Parhofer
1Department of Internal Medicine II, University of Munich, Munich, Germany.
Molecular Medicine (Cambridge, Mass.)
|November 15, 2008
Summary
Obesity links to many health issues. Adipose tissue hormones like adiponectin and leptin significantly impact insulin resistance, affecting metabolism and inflammation.
Area of Science:
- Endocrinology
- Metabolic Syndrome
- Obesity Research
Background:
- Obesity is a growing global health concern linked to numerous comorbidities.
- Adipose tissue functions as an endocrine organ, secreting adipokines.
- Adipokines influence systemic metabolism, inflammation, and cardiovascular health.
Purpose of the Study:
- To review the current understanding of adipose tissue-derived hormones.
- To elucidate the role of specific adipokines in insulin resistance.
- To consolidate knowledge on the endocrine function of adipose tissue in metabolic disease.
Main Methods:
- Literature review of current scientific data.
- Analysis of studies investigating adipokine function.
- Synthesis of research on hormone-specific effects on insulin resistance.
Main Results:
- Adipose tissue secretes numerous bioactive mediators (adipokines).
- Key adipokines reviewed include adiponectin, chemerin, leptin, omentin, resistin, RBP4, TNF-α, IL-6, vaspin, and visfatin.
- These hormones modulate insulin sensitivity and are implicated in metabolic dysfunction.
Conclusions:
- Adipose tissue plays a critical role in metabolic regulation through adipokine secretion.
- Understanding these hormones is crucial for addressing obesity and its associated insulin resistance.
- Further research into adipokines may reveal novel therapeutic targets for metabolic disorders.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...